Dabigatran in clinical practice - One-year experience at skåne university hospital

Thrombosis Research

Volumn 132, Issue 2, 2013, Pages 316-317

  Bergman, Elin ^a   Smith, J Gustav ^a   Wieloch, Mattias ^a   Braun, Oscar Ö ^a   Svensson, Peter ^a   Van Der Pals, Jesper ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; DABIGATRAN; THROMBIN INHIBITOR; WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; BLEEDING; BLOOD TRANSFUSION; CEREBROVASCULAR ACCIDENT; CLINICAL PRACTICE; CLINICAL PROTOCOL; CREATININE BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG MEGADOSE; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL HEMORRHAGE; GLOMERULUS FILTRATION RATE; HEART ATRIUM FIBRILLATION; HEMOGLOBIN DETERMINATION; HUMAN; KIDNEY FUNCTION; LETTER; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; REGISTER; RETROSPECTIVE STUDY; RISK; SCORING SYSTEM; SWEDEN; THROMBOSIS; TREATMENT OUTCOME; UNIVERSITY HOSPITAL;

AGED; ANTITHROMBINS; ATRIAL FIBRILLATION; BENZIMIDAZOLES; BETA-ALANINE; FEMALE; HUMANS; MALE; REGISTRIES; STROKE; SWEDEN;

EID: 84883826826     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2013.04.013     Document Type: Letter

References (7)

1. S.J. Connolly, M.D. Ezekowitz, S. Yusuf, J. Eikelboom, J. Oldgren, and A. Parekh Dabigatran versus warfarin in patients with atrial fibrillation N Engl J Med 361 2009 1139 1151
2. M. Wieloch, A. Själander, V. Frykman, M. Rosenqvist, N. Eriksson, and P.J. Svensson Anticoagulation control in Sweden: reports of time in therapeutic range, major bleeding, and thrombo-embolic complications from the national quality registry AuriculA Eur Heart J 32 2011 2282 2289
3. S. Schulman, and C. Kearon Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients J Thromb Haemost 3 2005 692 694
4. A.J. Camm, G.Y. Lip, R. De Caterina, I. Savelieva, D. Atar, and S.H. Hohnloser focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation -developed with the special contribution of the European Heart Rhythm Association Europace 14 2012 1385 1413
5. J. Björk, S.E. Bäck, G. Sterner, J. Carlson, V. Lindstrom, and O. Bakoush Prediction of relative glomerular filtration rate in adults: new improved equations based on Swedish Caucasians and standardized plasma-creatinine assays Scand J Clin Lab Invest 67 2007 678 695
6. J.C. Ho, A.M. Chang, B.P. Yan, C.M. Yu, Y.Y. Lam, and V.W. Lee Dabigatran Compared With Warfarin for Stroke Prevention With Atrial Fibrillation: Experience in Hong Kong Clin Cardiol 22 2012 50 55
7. J. Michel, D. Mundell, T. Boga, and A. Sasse Dabigatran for Anticoagulation in Atrial Fibrillation - Early Clinical Experience in a Hospital Population and Comparison to Trial Data Heart Lung Circ 35 2012 E40 E45